Connexin 43 deficiency accelerates skin wound healing and extracellular matrix remodeling in mice

Journal of Dermatological Science

Volumn 79, Issue 1, 2015, Pages 50-56

  Cogliati, Bruno ^a   Vinken, Mathieu ^b   Silva, Tereza C ^a   Araújo, Cintia M M ^a   Aloia, Thiago P A ^a   Chaible, Lucas M ^a   Mori, Cláudia M C ^a   Dagli, Maria L Z ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Connexin 43; Gap junction; Skin repair; Wound healing

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNEXIN 43; GELATINASE A; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; COLLAGEN METABOLISM; COLLAGEN TYPE I GENE; COLLAGEN TYPE III GENE; CONTROLLED STUDY; CX43 GENE; EPITHELIZATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; MALE; MMP2 GENE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; TGF BETA1 GENE; WOUND CLOSURE; WOUND HEALING; ANGIOGENESIS; ANIMAL; DEFICIENCY; FIBROBLAST; GENETICS; HETEROZYGOTE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL PROLIFERATION; COLLAGEN; CONNEXIN 43; EXTRACELLULAR MATRIX; FIBROBLASTS; HETEROZYGOTE; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RE-EPITHELIALIZATION;

EID: 84929955715     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2015.03.019     Document Type: Article

References (35)

1. Becker D.L., Thrasivoulou C., Phillips A.R. Connexins in wound healing; perspectives in diabetic patients. Biochim Biophys Acta 2012, 1818:2068-2075.
2. Scott C.A., Tattersall D., O'Toole E.A., Kelsell D.P. Connexins in epidermal homeostasis and skin disease. Biochim Biophys Acta 2012, 1818:1952-1961.
3. Churko J.M., Laird D.W. Gap junction remodeling in skin repair following wounding and disease. Physiology 2013, 28:190-198.
4. Martin P.E., Easton J.A., Hodgins M.B., Wright C.S. Connexins: sensors of epidermal integrity that are therapeutic targets. FEBS Lett 2014, 588:1304-1314.
5. Coutinho P., Qiu C., Frank S., Wang C.M., Brown T., Green C.R., et al. Limiting burn extension by transient inhibition of connexin 43 expression at the site of injury. Br J Plast Surg 2005, 58:658-667.
6. Pollok S., Pfeiffer A.C., Lobmann R., Wright C.S., Moll I., Martin P.E., et al. Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med 2011, 15:861-873.
7. Brandner J.M., Houdek P., Hüsing B., Kaiser C., Moll I. Connexins 26, 30, and 43: differences among spontaneous, chronic, and accelerated human wound healing. J Investig Dermatol 2004, 122:1310-1320.
8. Kretz M., Euwens C., Hombach S., Eckardt D., Teubner B., Traub O., et al. Altered connexin expression and wound healing in the epidermis of connexin-deficient mice. J Cell Sci 2003, 116:3443-3452.
9. Qiu C., Coutinho P., Frank S., Franke S., Law L.Y., Martin P., et al. Targeting connexin 43 expression accelerates the rate of wound repair. Curr Biol 2003, 13:1697-1703.
10. Mori R., Power K.T., Wang C.M., Martin P., Becker D.L. Acute downregulation of connexin 43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. J Cell Sci 2006, 119:5193-5203.
11. Lu F., Gao J., Ogawa R., Hyakusoku H. Variations in gap junctional intercellular communication and connexin expression in fibroblasts derived from keloid and hypertrophic scars. Plast Reconstr Surg 2007, 119:844-851.
12. Wang C.M., Lincoln J., Cook J.E., Becker D.L. Abnormal connexin expression underlies delayed wound healing in diabetic skin. Diabetes 2007, 56:2809-2817.
13. Reaume A.G., de Sousa P.A., Kulkarni S., Langille B.L., Zhu D., Davies T.C., et al. Cardiac malformation in neonatal mice lacking connexin 43. Science 1995, 267:1831-1834.
14. Cogliati B., Da Silva T.C., Aloia T.P., Chaible L.M., Real-Lima M.A., Sanches D.S., et al. Morphological and molecular pathology of CCL4-induced hepatic fibrosis in connexin 43-deficient mice. Microsc Res Tech 2011, 74:421-429.
15. Birch M., Tomlinson A., Ferguson M.W. Animal models for adult dermal wound healing. Methods Mol Med 2005, 117:223-235.
16. Madden J.W., Peacock E.E. Studies on the biology of collagen during wound healing. Rate of collagen synthesis and deposition in cutaneous wounds in the rat. Surgery 1968, 64:288-294.
17. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622.
18. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
19. Loewenstein W.R., Kanno Y. Intercellular communication and tissue growth. I. Cancerous growth. J Cell Biol 1967, 33:225-234.
20. Revel J.P., Karnovsky M.J. Hexagonal array of subunits in intercellular junctions of the mouse heart and liver. J Cell Biol 1967, 33:C7-C12.
21. Goodenough D.A. Bulk isolation of mouse hepatocyte gap junctions. Characterization of the principal protein, connexin. J Cell Biol 1974, 61:557-563.
22. Yamasaki H., Naus C.C. Role of connexin genes in growth control. Carcinogenesis 1996, 17:1199-1213.
23. Willecke K., Hennemann H., Dahl E., Jungbluth S., Heynkes R. The diversity of connexin genes encoding gap junctional proteins. Eur J Cell Biol 1999, 1:1-7.
24. Yamasaki H. Role of disrupted gap junctional intercellular communication in detection and characterization of carcinogens. Mutat Res 1996, 365:91-105.
25. Trosko J.E., Ruch R.J. Cell-cell communication in carcinogenesis. Front Biosci 1998, 3:d208ÿd236.
26. Trosko J.E., Ruch R.J. Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets 2002, 3:465-482.
27. Chanson M., Derouette J.P., Roth I., Foglia B., Scerri I., Dudez T., et al. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta 2005, 1711:197-207.
28. Essenfelder G.M., Bruzzone R., Lamartine J., Charollais A., Blanchet-Bardon C., Barbe M.T., et al. Connexin30 mutations responsible for hydrotic ectodermal dysplasia cause abnormal hemichannel activity. Hum Mol Genet 2004, 13:1703-1714.
29. Gerido D.A., DeRosa A.M., Richard G., White T.W. Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness. Am J Physiol Cell Physiol 2004, 293:C337-C345.
30. Mese G., Sellitto C., Li L., Wang H.Z., Valiunas V., Richard G., et al. The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome. Mol Biol Cell 2011, 22:4776-4786.
31. Mhaske P.V., Levit N.A., Li L., Wang H.Z., Lee J.R., Shuja Z., et al. The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity. Am J Physiol Cell Physiol 2013, 304:C1150-C1158.
32. Abdullah K.M., Luthra G., Bilski J.J., Abdullah S.A., Reynolds L.P., Redmer D.A., et al. Cell-to-cell communication and expression of gap junctional proteins in human diabetic and nondiabetic skin fibroblasts: effects of basic fibroblast growth factor. Endocrine 1999, 10:35-41.
33. Bajpai S., Shukla V.K., Tripathi K., Srikrishna S., Singh R.K. Targeting connexin 43 in diabetic wound healing: future perspectives. J Postgrad Med 2009, 55:143-149.
34. Wright C.S., van Steensel M.A., Hodgins M.B., Martin P.E. Connexin mimetic peptides improve cell migration rates of human epidermal keratinocytes and dermal fibroblasts in vitro. Wound Repair Regen 2009, 17:240-249.
35. Wright C.S., Pollok S., Flint D.J., Brandner J.M., Martin P.E. The connexin mimetic peptide Gap27 increases human dermal fibroblast migration in hyperglycemic and hyperinsulinemic conditions in vitro. J Cell Physiol 2012, 227:77-87.